The companies are introducing their diclofenac sodium topical gel 1% in 50-, 100- and 150-g laminate tubes after receiving Food and Drug Administration approval, and are partnering to bring the product to U.S. retailers.
PLD is a New York-based pharmaceutical company that develops and commercializes solid and liquid dose remedies for analgesic, cough and allergy diseases.